Ovid Therapeutics Inc logo

OVID

Materials

Ovid Therapeutics Inc

$2.78-0.05 (-1.77%)PRE

Live · NASDAQ · May 9, Close

AI Insight

What's Moving OVID Today?

No stock-specific AI insight has been generated for OVID yet. Check back soon — insights are generated from recent news analysis.

Fundamentals

Market Cap$481M
P/E Ratio
EPS
Dividend Yield
Dividend / Share
ROE
Profit Margin
Debt / Equity

Trading

Volume2.6M
Avg Volume (10D)
Shares Outstanding173.0M

OVID News

20 articles

All 20 articles loaded

Price Data

Open$2.83
Previous Close$2.83
Day High$2.95
Day Low$2.75
52 Week High
52 Week Low

About Ovid Therapeutics Inc

Ovid Therapeutics Inc is a biopharmaceutical company that is dedicated to reducing seizures and meaningfully improving the lives of people affected by rare epilepsies and seizure-related neurological disorders. The company has built a differentiated pipeline of medicines with potential first-in-class drug mechanisms of action to treat seizures. This pipeline has produced two epilepsy programs with potential first-in-class mechanisms of action, and one epilepsy program with a potential best-in-class mechanism of action.

23 employees
Listed May 5, 2017
MaterialsPHARMACEUTICAL PREPARATIONS

Company Details

Security TypeStock
ExchangeNASDAQ
Currency
Round Lot
SICPHARMACEUTICAL PREPARATIONS
CIK
Composite FIGI
Share Class FIGI